BUILDING CHINA BRIDGES · GLOBAL HEALTH
China Global Health
The next opportunity in international healthcare is to connect the right care across borders — with China as one anchor in a network that begins and ends close to the patient.
A patient might be best assessed near home, treated at a qualified specialist center abroad, and supported through recovery in a regional hub. Today those stages often behave like separate systems. The opportunity is to design one accountable journey across them.
From a destination to a delivery network
China may be able to make selected healthcare capabilities available internationally at scale. The credible proposition begins specialty by specialty and provider by provider, with demonstrated outcomes, available capacity, safe handovers and transparent total episode cost. Regional and home-market institutions should retain meaningful roles in diagnosis, preparation, rehabilitation and continuing care.
The first choice is which patient journeys to serve. Advanced specialist care and elective personal care have different buyers, proof requirements and clinical pathways. They can share a secure operating backbone, but should not be marketed or managed as one product.
Three ways the 2035 network could develop
| Case | Patients / year | Specialist | Elective | Provider revenue | Provider EBITDA |
|---|---|---|---|---|---|
| Low | 0.91m | 0.13m | 0.78m | $2.35bn | $0.29bn |
| Base | 2.63m | 0.32m | 2.31m | $10.77bn | $2.21bn |
| High | 6.13m | 0.69m | 5.44m | $39.77bn | $11.49bn |
Illustrative Katalyx 2035 base scenario: 2.63 million annual physical patient episodes, of which 0.32 million are advanced specialist and 2.31 million elective/personal. This is a planning scenario, not a forecast, current flow or validated market size. The segment areas are proportional to the modeled episode counts. The low and high cases are roughly 35% and 233% of the base patient count. Revenue rises faster than episodes because the cases also assume different service mix and realized value. Provider EBITDA is an illustrative provider-level result, not profit for the coordinating network. None of these figures represents existing international demand.
“One front door. The right qualified provider. One agreed pathway. Continuing care near home.
Choose corridors and specialties together
A promising source market is not simply one with many people. The first corridors need a documented gap in a specific service, patients who can travel, a credible home referral partner, affordable total episode costs, permission to move records and payments, and a provider able to accept patients back. Each country below is a candidate for diligence, not a ranked market or committed launch.
South & Southeast Asia
Pakistan, Bangladesh, Vietnam, Cambodia and MyanmarTest accessible planned care and regional follow-up before complex referrals.
Central Asia
Kazakhstan and UzbekistanExamine specialist referral gaps, language support and travel links.
Africa & Middle East
Nigeria, Egypt, Algeria, Kenya, Tanzania, Iraq and selected Gulf gatewaysAssess institutional referral pathways, regional preparation and payer feasibility.
Two launch portfolios, different proof
Specialist referral
Selected oncology, cardiovascular care, complex surgery and advanced diagnostics demand outcome evidence, case review, escalation capacity and referral agreements.
Planned personal care
Ophthalmology, dentistry, orthopedics, fertility, screening and rehabilitation demand price transparency, suitability screening and reliable follow-up.
Make every handover visible and owned
The operating unit is a complete episode, not an international hospital booking. A home provider keeps the patient relationship, a regional gateway can assemble diagnostics and recovery support, and a qualified Chinese center performs a selected intervention when it is clinically appropriate. A network orchestrator connects decisions, records, consent, travel and payment. A named human companion helps the patient and family navigate practical transitions; clinical decisions stay with licensed professionals.
HOME PROVIDER
Local assessment, referral and long-term follow-up
REGIONAL GATEWAY
Diagnostics, case preparation, recovery and escalation
CHINESE CENTER
Qualified specialist intervention and documented discharge
HOME / REGION
Accepted handover, rehabilitation and continuing care
CLINICAL PATHWAY · suitability, consent, treatment, discharge, aftercare
OPERATING LAYER · record, case owner, authorization, quotation, travel, settlement
HUMAN LAYER · named patient companion, language support and family communication
Build a system that earns the right to scale
A useful app is only one component. The network needs clinical proof, a shared case workflow, human continuity and governance that can withstand complications and conflicting incentives. The first corridor should be chosen for a manageable pathway and willing clinical partners, not the largest theoretical patient pool. Beijing, Shanghai, Guangzhou, Shenzhen, Hainan and Chengdu are possible Chinese anchors to assess specialty by specialty; a city name alone is no quality credential.
Clinical proof
Select two or three pathways; verify provider outcomes, eligibility, capacity and full episode value
Connected case system
Portable records, referrals, task ownership, consent, quotations, payments and audited handovers
Human continuity
A named case owner and patient companion, backed by interpreters and an escalation desk
Network governance
Independent quality review, transparent routing, clear liability and corridor-specific permissions
The shared memory of the system
Standards such as HL7 FHIR and DICOM can help exchange clinical records and imaging. They do not settle identity, translation, consent, data-transfer rights or clinical responsibility. Those require provider agreements, governance and review in each corridor.
Launch sequence
Compare clinical outcomes and total costs; qualify pathways and partners
Run live cases in one or two corridors with accepted return handovers
Standardize contracts, interfaces, payer workflows and outcome reporting
Expand only where quality, economics and compliance remain demonstrable
The test is the whole episode
A network succeeds when the patient receives appropriate care, understands the next step, returns to an accepting local provider, and sees transparent outcomes and full costs. The first pilot should report accepted handovers, complications and resolution, patient experience, realized episode cost and provider outcomes before any expansion. China need not own every part of that chain. It could help build and anchor a system in which each partner creates value where it is strongest.
Based on Katalyx’s August 2026 China Global Health opportunity note and full opportunity report. Provider choices, corridors, partnerships, benefits and 2035 scenarios are strategic hypotheses requiring validation. The scenarios count physical patient episodes and provider medical-services revenue separately from platform, travel and hospitality activity. No clinical result or cost saving is asserted here.The full opportunity report is available on request
We would be pleased to share the detailed report and discuss how to test the first care corridors
Request the full report ↗